|
Gender (male)
|
76 (64.4%)
|
|
Age (mean±SD)
|
63.6±17.5 years
|
|
Smoking
|
31 (26.3%)
|
|
Alcohol drinking
|
18 (15.3%)
|
|
Concomitant disease
|
|
Chronic lung diseases
|
7 (5.9%)
|
|
Cerebrovascular diseases
|
7 (5.9%)
|
|
Cardiovascular diseases
|
53 (44.9%)
|
|
Renal failure
|
7 (5.9%)
|
|
Cancer diseases
|
12 (10.2%)
|
|
Liver disease
|
12 (10.2%)
|
|
Diabetes mellitus
|
25 (21.2%)
|
|
Juxtapapillary diverticulum
|
45 (38.1%)
|
|
Gallbladder stones
|
86 (72.9%)
|
|
Biliary pancreatitis
|
24 (20.3%)
|
|
CBD diameter (mean±SD)
|
1.2±0.4 cm
|
|
Number of CBD stones (no/single /multiple)
|
23/59/36 (20/50/30)
|
|
Largest CBD stones size (mean±SD)a
|
0.9±0.4 cm
|
|
Endoscopic procedures (EST/EPBD)
|
5/113 (4/96)
|
|
Mean balloon diameter for EPBD (mean±SD)
|
1.1±0.2 cm
|
|
Mechanical lithotripsy
|
12 (10.2%)
|
|
Sessions for bile duct clearance(> 1 session)
|
8 (6.8%)
|
|
Stone colora
|
|
Cholesterol and black pigment stones
|
44 (46%)
|
|
Brown pigment stones
|
51 (54%)
|
|
Mean ERCP procedure time (mean±SD)
|
49.2±22.2 min
|
|
Postprocedural complications
|
4 (3.4%)
|
|
Follow up time (median, range) months
|
33 (15 to 56)
|
|
Recurrent biliary complications
|
23 (19.5%)
|
|
Spontaneous passage of gallstones
|
15 (15/86 = 17.4%)
|
|
Death during follow up
|
6 (5.1%)
|
